XML 28 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Leases
3 Months Ended
Mar. 31, 2019
Leases [Abstract]  
Leases
Leases

The Company currently has operating and finance leases for office and research laboratory space, equipment and vehicles under agreements expiring at various dates through 2044. Certain of the Company's leases contain renewal options to extend the lease for up to 25 years.
For the three months ended March 31, 2019, lease expense was $2.1 million and $0.1 million for operating and finance leases, respectively. Cash paid for amounts included in the measurement of operating lease liabilities was $1.4 million for the three months ended March 31, 2019. For the three months ended March 31, 2019, the Company recorded $19.5 million of right-of-use assets obtained in exchange for new operating lease liabilities.
Commitments under finance leases are not significant.
Supplemental balance sheet information related to operating leases was as follows.     
(in thousands, except year and discount rate amounts)
 
March 31, 2019
Operating lease ROU asset
 
$
36,208

 
 
 
Current portion of the operating lease liabilities
 
$
2,421

Non-current portion of the operating lease liabilities
 
35,991

Total operating lease liability
 
$
38,412

 
 
 
Weighted-average remaining lease terms (years)
 
14.6

Weighted-average discount rate
 
12.8
%


At March 31, 2019, the future minimum lease payments were as follows:
( in thousands)
 
Operating Leases
2019 (excludes the three months ended March 31, 2019)
 
$
4,494

2020
 
9,776

2021
 
10,516

2022
 
10,418

2023
 
10,830

Thereafter
 
174,006

Total lease payments
 
$
220,040

Less lease incentives
 
(28,939
)
Less imputed interest
 
(152,689
)
Total operating lease liability
 
$
38,412



At December 31, 2018, the future minimum lease payments were as follows:
( in thousands)
 
Operating Leases
2019
 
$
6,244

2020
 
4,063

2021
 
3,560

2022
 
3,371

2023
 
3,611

Thereafter
 
10,038

Total lease payments
 
$
30,887

Leases
Leases

The Company currently has operating and finance leases for office and research laboratory space, equipment and vehicles under agreements expiring at various dates through 2044. Certain of the Company's leases contain renewal options to extend the lease for up to 25 years.
For the three months ended March 31, 2019, lease expense was $2.1 million and $0.1 million for operating and finance leases, respectively. Cash paid for amounts included in the measurement of operating lease liabilities was $1.4 million for the three months ended March 31, 2019. For the three months ended March 31, 2019, the Company recorded $19.5 million of right-of-use assets obtained in exchange for new operating lease liabilities.
Commitments under finance leases are not significant.
Supplemental balance sheet information related to operating leases was as follows.     
(in thousands, except year and discount rate amounts)
 
March 31, 2019
Operating lease ROU asset
 
$
36,208

 
 
 
Current portion of the operating lease liabilities
 
$
2,421

Non-current portion of the operating lease liabilities
 
35,991

Total operating lease liability
 
$
38,412

 
 
 
Weighted-average remaining lease terms (years)
 
14.6

Weighted-average discount rate
 
12.8
%


At March 31, 2019, the future minimum lease payments were as follows:
( in thousands)
 
Operating Leases
2019 (excludes the three months ended March 31, 2019)
 
$
4,494

2020
 
9,776

2021
 
10,516

2022
 
10,418

2023
 
10,830

Thereafter
 
174,006

Total lease payments
 
$
220,040

Less lease incentives
 
(28,939
)
Less imputed interest
 
(152,689
)
Total operating lease liability
 
$
38,412



At December 31, 2018, the future minimum lease payments were as follows:
( in thousands)
 
Operating Leases
2019
 
$
6,244

2020
 
4,063

2021
 
3,560

2022
 
3,371

2023
 
3,611

Thereafter
 
10,038

Total lease payments
 
$
30,887